sulfasalazine has been researched along with Angioimmunoblastic Lymphadenopathy in 4 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine." | 7.70 | Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000) |
| "We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine." | 3.70 | Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000) |
| "A 20-year-old man with ulcerative colitis was admitted because of fever, eruption and lymphadenopathy." | 1.29 | Salazosulfapyridine-induced angioimmunoblastic lymphadenopathy. ( Goto, M; Hatta, K; Imanaka, T; Kobashi, Y; Nakano, A, 1996) |
| "Nine months later she developed angioimmunoblastic lymphadenopathy and was found to have intestinal villous atrophy." | 1.27 | Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy. ( Smith, MA; Steele, PR; Youngs, GR, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, WH | 1 |
| Zhang, HY | 1 |
| Li, XF | 1 |
| Ma, Y | 1 |
| Nakano, A | 1 |
| Hatta, K | 1 |
| Kobashi, Y | 1 |
| Goto, M | 1 |
| Imanaka, T | 1 |
| Pay, S | 1 |
| Dinc, A | 1 |
| Simsek, I | 1 |
| Can, C | 1 |
| Erdem, H | 1 |
| Smith, MA | 1 |
| Steele, PR | 1 |
| Youngs, GR | 1 |
4 other studies available for sulfasalazine and Angioimmunoblastic Lymphadenopathy
| Article | Year |
|---|---|
[Drug-induced lymphadenitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; CD3 Complex; Colitis, Ulcerative; Diagnosis, Differe | 2010 |
Salazosulfapyridine-induced angioimmunoblastic lymphadenopathy.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Immunoblastic | 1996 |
Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Chloroquine; Humans; Immunoblastic Lymphadenopathy | 2000 |
Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy.
Topics: Aged; Atrophy; Duodenum; Female; Glutens; Humans; Ileitis; Immunoblastic Lymphadenopathy; Microvilli | 1985 |